Abstract:As a natural derivative of bioactive xanthone mangiferin, neomangiferin exhibits a wide spectrum of bioactivities. However, studies have yet to elucidate the metabolic pathways and pharmacokinetics of orally administered neomangiferin in vivo. In this study, a simple and accurate high-performance liquid chromatography/diode array detector method was developed and validated to simultaneously determine neomangiferin and its active metabolite mangiferin in plasma after oral and intravenous administration of neomangiferin to rats. Chromatographic separation was performed in a C18 column by using water containing 0.1% formic acid-acetonitrile (88:12, v/v) at a flow rate of 0.7 mL/min. The calibration curves of neomangiferin and mangiferin in rat plasma were linear at 150-15000 (r=0.9999) and 50-1500 ng/mL (r=0.9994), respectively. The relative standard deviations of intraday and inter-day precision were below 10.7%, and accuracy ranged from 94.0 to 105.5% for both analytes. Experimental results showed that intravenously and orally administered neomangiferin was partly metabolized into mangiferin. Tmax of neomangiferin and mangiferin was low (0.05 h), and the two components were eliminated at t1/2 of 0.95 and 0.73 h, respectively. Similar to that of mangiferin, the oral bioavailability of neomangiferin was also low (about 0.32%). Thirty-three metabolites were detected and absolutely or tentatively identified on the basis of mass spectral fragmentation pattern and elution order or were confirmed by using available reference standards. Our findings suggested that neomangiferin undergoes rapid and extensive phases I and II metabolic processes, such as deglycosylation, dehydroxylation, methylation, glycosylation, glucuronidation, and sulfation, in rats. In general, the pharmacokinetic and metabolic profiles, including poor bioavailability, high absorption and elimination rates, extensive biotransformation, of neomangiferin are similar to those of mangiferin to some degrees.

Bio- and chemical syntheses of mangiferin and congeners

Total synthesis of mangiferin, homomangiferin, and neomangiferin

Semi-Synthesis of Neomangiferin from Mangiferin.

Semi-Synthesis of Neomangiferin from Mangiferin

Semi-synthesis of Mangiferin-7-o-β-d-glucuronide

In-depth analysis of the chemical composition, pharmacological effects, pharmacokinetics, and patent history of mangiferin

Therapeutic and cosmetic applications of mangiferin: a patent review

Improving Aqueous Solubility of Natural Antioxidant Mangiferin through Glycosylation by Maltogenic Amylase from Parageobacillus galactosidasius DSM 18751

Synthesis and Antitumor Activities of Α-,Γ-mangostin Derivatives

Mangiferin: an Effective Therapeutic Agent Against Several Disorders (Review)

A comprehensive review on the synthesis of mangiferin derivatives and their multiple biological activities

Synthesis and Antitumor Activities of alpha-,gamma-mangostin Derivatives

Unprecedented Natural Mangiferin Excimer Induced Aggregation-Induced Emission Luminogens for Highly Selective Bioimaging of Cancer Cells

The Pharmacokinetics and Metabolism of Neomangiferin, a Major Bioactive Component in Anemarrhena asphodeloides

A Concise and Efficient Total Synthesis of Α-Mangostin and Β-Mangostin from Garcinia Mangostana

Comprehensive Profiling of Mangiferin Metabolites In Vivo and In Vitro Based on the "Drug Metabolite Clusters" Analytical Strategy

Pharmacology of Mangostins and Their Derivatives: A Comprehensive Review

Nano-delivery Systems and Therapeutic Applications of Phytodrug Mangiferin

Explaining the interaction of mangiferin with MMP-9 and NF-ƙβ: a computational study

Toward the Bioactive Potential of Myricitrin in Food Production: State-of-the-art Green Extraction and Trends in Biosynthesis

α-Mangostin: A Xanthone Derivative in Mangosteen with Potent Anti-Cancer Properties